Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Nijmeegse spin-off zoekt met AI nieuwe mugwerende middelen
sep 2021 | Parasitaire infecties, Virale infecties